Abivax S.A.
ABVX | NASDAQ
$104.01
-$1.03 (-0.98%)
Sep 21, 2026, 9:39 AM ET · Market open
TTM Period Ending | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 2.33M | 4.57M | 4.5M | 4.48M | 2.23M | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 378K | 707K | 361K | 71K | 163K | 156K | 65K | 66K | 68K |
Gross Profit | n/a | n/a | n/a | 2.33M | 4.57M | 4.5M | 4.48M | 2.1M | -156K | -65K | -66K | -68K |
Operating Income | -246.06M | -93.7M | -82.53M | -127.79M | -132M | -78.34M | -57.43M | -44.31M | -52.22M | -49.92M | -39.6M | -32.28M |
Interest Income | 1.13M | 1.41M | 3.54M | 2.45M | n/a | 113K | 128K | 99K | 84K | n/a | n/a | 4K |
Pretax Income | -330.25M | -100.78M | -91.14M | -136.82M | -152.23M | -96.74M | -74.32M | -59.19M | -45.56M | -42.85M | -40.13M | -32.38M |
Net Income | -336.1M | -100.78M | -91.14M | -134.56M | -147.74M | -92.25M | -69.85M | -54.38M | -41.36M | -38.66M | -37.55M | -31.88M |
Selling & General & Admin | 36.63M | 17.84M | 20.94M | 33.58M | 28.11M | 11.85M | 7.49M | 4.52M | 4.75M | 4.73M | 4.98M | 4.66M |
Research & Development | 83.04M | 77.95M | 68.21M | 99.46M | 103.18M | 65.46M | 47.95M | 38.35M | 47.2M | 45.01M | 34.53M | 27.49M |
Other Expenses | 126.38M | -2.09M | -6.62M | -5.63M | -7K | -8K | 10.93M | 10.95M | 113K | 111K | 6K | 44K |
Operating Expenses | 246.06M | 93.7M | 82.53M | 127.41M | 131.29M | 77.2M | 66.25M | 53.83M | 52.06M | 49.85M | 39.53M | 32.21M |
Interest Expense | 18.8M | 8.06M | 8.36M | 9.53M | 20.4M | 16.51M | 3.93M | 4.3M | 3.21M | 2.39M | 2.32M | 1.96M |
Selling & Marketing Expenses | 48K | 206K | 524K | 6.25M | 5.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 246.06M | 93.7M | 82.53M | 127.79M | 132M | 77.56M | 56.65M | 44.31M | 52.22M | 49.92M | 39.6M | 32.28M |
Income Tax Expense | 5.85M | n/a | n/a | -2.26M | -4.49M | -4.49M | -4.48M | -4.81M | -4.2M | -4.19M | -2.58M | -498K |
Shares Outstanding (Basic) | 69.53M | 63.41M | 63.17M | 62.92M | 48.29M | 35.9M | 22.3M | 16.77M | 16.76M | 14.66M | 14.31M | 12.21M |
Shares Outstanding (Diluted) | 69.53M | 63.41M | 63.17M | 62.92M | 48.29M | 35.9M | 22.3M | 16.77M | 16.76M | 14.66M | 14.31M | 12.21M |
EPS (Basic) | -3.69 | -3.09 | -2.15 | -2.63 | -3.43 | -3.26 | -3.57 | -3.24 | -2.61 | -2.68 | -2.81 | -2.61 |
EPS (Diluted) | -3.69 | -3.09 | -2.15 | -2.63 | -3.43 | -3.26 | -3.57 | -3.24 | -2.61 | -2.68 | -2.81 | -2.61 |
EBITDA | -300.7M | -92.2M | -82.14M | -126.66M | -131.29M | -75.35M | -51.17M | -40.14M | -51.62M | -49.85M | -39.53M | -32.11M |
EBIT | -301.77M | -92.73M | -82.78M | -127.29M | -131.83M | -75.68M | -51.23M | -40.29M | -51.76M | -49.87M | -39.56M | -32.18M |
Depreciation & Amortization | 1.07M | 524K | 638K | 743K | 707K | 361K | 71K | 163K | 156K | 65K | 66K | 68K |
Add to Watchlist
Select watchlists to add or remove ABVX